EPHB3 controls cell positioning, restricts cell motility, and acts as a tumor suppressor. Recently, EPHB3 expression was correlated with better clinical outcomes and longer overall survival, suggesting that EPHB3 is a prognostic indicator in CRC. This evidence concerns the gene EPHB3 and colorectal carcinoma.